Related Experiment Video

Updated: Feb 2, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.6K

Methicillin-resistant staphylococcus aureus pneumonia in older people: a diagnostic and therapeutic challenge

M Kiselinova1,2, A Velghe1,2, R Piers1,2

  • 1Department of Internal Medicine, University Hospital Ghent , Ghent , Belgium.

Acta Clinica Belgica
|November 17, 2018
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a severe infection in older adults, often presenting with rapid decline and poor outcomes. Early recognition and appropriate antibiotic therapy are crucial for managing this high-mortality condition.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Bacteriology

Background:

  • Pneumonia is a leading cause of mortality in the elderly, with Staphylococcus aureus being a significant bacterial pathogen.
  • The emergence of antibiotic resistance has led to strains like methicillin-resistant Staphylococcus aureus (MRSA), posing a growing threat.
  • MRSA pneumonia, while less common in older adults, carries an exceptionally high mortality rate.

Observation:

  • This report details two cases of MRSA pneumonia in the geriatric population, emphasizing its severe clinical presentation and virulence.
  • MRSA pneumonia often exhibits rapid clinical deterioration and a poor prognosis.
  • Key risk factors include comorbidities, recent antibiotic use, prior MRSA infections, and institutionalization.

Findings:

  • Accurate empirical treatment is challenging due to MRSA's low prevalence and non-specific clinical features in this demographic.
  • Current first-line treatments for adult MRSA infections include monotherapy with vancomycin or linezolid.
  • There is a lack of specific treatment guidelines for MRSA pneumonia in older patients, despite age-related mortality risks.

Implications:

  • Clinicians must maintain a high index of suspicion for MRSA pneumonia in at-risk older patients.
  • Further research is needed to develop targeted treatment strategies and guidelines for MRSA pneumonia in the geriatric population.
  • Improved diagnostic and therapeutic approaches are essential to reduce the high mortality associated with MRSA pneumonia in the elderly.
Keywords:
Methicillin-resistant S. Aureus MRSAcommunity-acquired pneumoniahealth care-associated pneumoniaolder people

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.6K
Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus09:03

Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus

Published on: September 5, 2013

12.4K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
892
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
815
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K